Twenty-eight states have bills that would either restrict medical boards’ authority to discipline clinicians who prescribe the unproven COVID-19 treatment, allow off-label use of the medication or both. Many of these states are concentrated in the Midwest and Southeast.
The legislation reflects growing political pressure to restrict boards’ authority to penalize physicians over health misinformation.
In July 2021, the Federation of State Medical Boards warned that physicians spreading COVID-19 misinformation online and in the media may be at risk of losing their medical licenses. However, medical boards penalized just eight physicians in 2021 for furthering such misinformation, according to Politico.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
